The oncology patient pathway includes a series of steps that a cancer patient goes through: from diagnosis to treatment and beyond. It considers all aspects of care including diagnoses, treatment planning, care delivery, follow-up care, and end-of-life care. The cancer patient journey is ideally designed to provide comprehensive and coordinated care for cancer patients and […]
Read MoreThe plaintiff unsuccessfully requested a statistical overview of the number of people who died for individual time periods from various causes after the ÚZIS. These questions may undoubtedly be a matter of legitimate public interest and therefore part of the public domain. According to the Constitutional Court (even taking into account the established jurisprudence of […]
Read MoreThe paper Delphi methodology in healthcare research: How to decide its appropriateness by P. Nasa, R. Jain, and D. Juneja appeared in the last year. Of course, this is not the first and certainly not the last paper dealing with the use of Delphi methods in healthcare, however, its clarity supports its introduction to Czech […]
Read MoreThree perspectives are most commonly used in economic evaluations in the healthcare sector: (1) the payer perspective, which includes only the costs and utility of a particular party such as the patient, employer, or insurer; (2) the health care perspective, which includes only the costs and utility within the health care sector; and last but […]
Read MoreManaged entry agreements (MEA) are arrangements that address uncertainty about the performance of technologies (mainly medicines) and simultaneously manage their adoption in order to maximize their effective use, or limit their budget impact. Basically, MEAs can be understood as a tool that gives patients an access to new medicines, while the risk of uncertain effectiveness […]
Read MoreThe early stage HTA (eHTA) is an assessment of health technologies at the stage of research and development. Lately, it has been an intensely investigated area of health technology assessment, most commonly used as a tool for identifying economic predictions of health technologies at an early stage of development, before clinical testing, and even before […]
Read MoreGajdoš, O.; Kamenský, V.; Doskočilová, K.; Caithamlová, M.; Kubátová, I. Cost-utility analysis of cardiovascular outpatient rehabilitation care and spa treatment care for patients with heart diseaseCost Effectiveness and Resource Allocation. 2020, 18(1), 1-10. ISSN 1478-7547.
Read More